Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


What Can Korean Pharma Do Right To Build R&D, Alliances?

This article was originally published in PharmAsia News

Executive Summary

What is an ideal R&D business model for the South Korean pharma industry and what are some of the key factors that could lead to successful novel research? At a recent meeting in Seoul, executives from leading domestic pharma companies including Yuhan and Hanmi shared their views and experience on how to develop valuable assets and seal successful international licensing deals.



Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts